Venous thromboembolism, that consists of the interrelated conditions deep-vein thrombosis
and pulmonary embolism, is an under-appreciated vascular disease. In Western regions …

PURPOSE Venous thromboembolism (VTE), especially pulmonary embolism (PE) and
lower extremity deep vein thrombosis (LE-DVT), is a serious and potentially preventable …

Patients with cancer have an increased risk of venous thromboembolism (VTE). Comparing
tumor-specific VTE risk is complicated by factors such as surgery, disease stage, and …

Background Thirty to seventy percent of all venous thromboembolism (VTE) events are
associated with hospitalization. The absolute and relative risks during and after …

Venous thromboembolism (VTE) is a significant complication for cancer patients undergoing
systemic therapy. We performed an independent external validation for a recently derived …

Background The relationship between metastatic colorectal cancer (mCRC) and venous
thromboembolism (VTE) is poorly defined in the modern era. Our objective was to examine …

Venous thromboembolism (VTE) is a common cause of morbidity and mortality in
hospitalized patients. Globally, it is also the third leading vascular disease, after myocardial …

Abstract Up to 15–20% of cancer patients experience one or more episodes of venous
thromboembolism during cancer disease. Approximately 80% of all cancer-associated …

Background Metabolic and bariatric surgery (MBS) has a low incidence of post-operative
morbidity and mortality. Understanding risk factors associated with complications that occur …

Objective To develop and confirm an individualized predictive model to ascertain the
probability of deep venous thrombosis in patients with acute poisoning after undergoing …